Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome

NCT00077116 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: busulfan
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: gemtuzumab ozogamicin
DRUG: idarubicin
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: radiation therapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC